1 Garcia CC, "The development of anti-inflammatory drugs for infectious diseases" 10 : 479-488, 2010
2 Krilov LR, "Respiratory syncytial virus disease: update on treatment and prevention" 9 : 27-32, 2011
3 Chisari FV, "Pathogenesis of hepatitis B virus infection" 58 : 258-266, 2010
4 Kim YW, "Novel anti-viral VSF protein and hybridoma producing the same US 7,514.082 B2"
5 Vezali E, "Interferon in the treatment of chronic hepatitis C: a drug caught between past and future" 11 : 301-313, 2011
6 Anthony WL, "How the SARS coronavirus causes disease: host or organism" 208 : 142-151, 2006
7 Grimm D, "HBV life cycle and novel drug targets" 5 : 644-653, 2011
1 Garcia CC, "The development of anti-inflammatory drugs for infectious diseases" 10 : 479-488, 2010
2 Krilov LR, "Respiratory syncytial virus disease: update on treatment and prevention" 9 : 27-32, 2011
3 Chisari FV, "Pathogenesis of hepatitis B virus infection" 58 : 258-266, 2010
4 Kim YW, "Novel anti-viral VSF protein and hybridoma producing the same US 7,514.082 B2"
5 Vezali E, "Interferon in the treatment of chronic hepatitis C: a drug caught between past and future" 11 : 301-313, 2011
6 Anthony WL, "How the SARS coronavirus causes disease: host or organism" 208 : 142-151, 2006
7 Grimm D, "HBV life cycle and novel drug targets" 5 : 644-653, 2011